C04331-2022

SECURITIES AND EXCHANGE COMMISSIONSEC FORM 17-C

CURRENT REPORT UNDER SECTION 17
OF THE SECURITIES REGULATION CODE
AND SRC RULE 17.2(c) THEREUNDER

1. Date of Report (Date of earliest event reported)
Jun 13, 2022
2. SEC Identification Number
CS200251064
3. BIR Tax Identification No.
219075614
4. Exact name of issuer as specified in its charter
MEDILINES DISTRIBUTORS INCORPORATED
5. Province, country or other jurisdiction of incorporation
MANDALUYONG CITY
6. Industry Classification Code(SEC Use Only)
7. Address of principal office
7 Pioneer St. Corner Sheridan St., Barangay Highway Hills, Mandaluyong City Postal Code 1550
8. Issuer's telephone number, including area code
+6377471016/+6385192012
9. Former name or former address, if changed since last report
NA
10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA
Title of Each Class Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
Common 2,750,000,800
11. Indicate the item numbers reported herein
Item 9

The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.

Medilines Distributors IncorporatedMEDIC

PSE Disclosure Form 4-31 - Press Release References: SRC Rule 17 (SEC Form 17-C)
Section 4.4 of the Revised Disclosure Rules

Subject of the Disclosure

Medilines records 65% YoY earnings growth, posts Php 170 million net profit for 2021

Background/Description of the Disclosure

Leading medical equipment supplier Medilines Distritbutors, Inc. [MEDIC] recorded earnings of Php170 million for 2021 from Php103 million in 2020, reflecting a record-breaking 65% year-on-year growth. A dual strategy of expanding its consumables product offerings as well as strong fiscal policies resulted to a double-digit growth in net profits at year-end December 2021...

Other Relevant Information

Please see attached PDF file for the full press release.

This press release may contain “forward-looking statements” which are subject to a number of risks and uncertainties that could affect the MEDIC’s business and results of operations. Although MEDIC believes that expectations reflected in any forward-looking statements are reasonable, it can give no guarantee of future performance, action or events.

Filed on behalf by:
Name Luis Melquiades Garcia III
Designation Investor Relations and Compliance Officer